Both SF3B1 (50%) and KIT (67%) mutations were most frequently mutated in tumors of female genital origin and anorectal region (33.3% for SF3B1 and KIT) compared to a single SF3B1 mutant conjunctival melanoma in the upper body sites (Figure 1B). This evidence concerns the gene KIT and melanoma.